Improving the ocular to systemic ratio of topical timolol by varying the dosing time
- PMID: 1894477
Improving the ocular to systemic ratio of topical timolol by varying the dosing time
Abstract
This study was performed to determine whether the ratio of ocular to systemic absorption of topically applied timolol in the pigmented rabbit can be maximized by varying the time of drop instillation. Twenty-five microliters of 0.65% timolol maleate solutions were instilled into the pigmented rabbit eye at 6 AM, 12 PM, 6 PM, or 12 AM. The time course of timolol concentration in plasma and various eye tissues (conjunctiva, sclera, corneal epithelium, corneal stroma, aqueous humor, iris-ciliary body, and lens) was monitored with the use of reversed phase high-performance liquid chromatography (HPLC). Ocular timolol concentrations were approximately twice as high when the drug was administered at 12 PM than at 6 AM, 6 PM, or 12 AM, whereas timolol concentration in plasma was lowest when the drug was administered at 12 PM. It may, therefore, be possible to maximize the therapeutic index of topically applied timolol by administering the drug at 12 PM. Moreover, the possible influence of dosing time on the extent of ocular and systemic drug absorption must be considered when planning dosing schedules for topically applied ophthalmic drugs.
Comment in
-
Circadian rhythm in physiology and pharmacology.Invest Ophthalmol Vis Sci. 1992 Nov;33(12):3480. Invest Ophthalmol Vis Sci. 1992. PMID: 1428722 No abstract available.
Similar articles
-
Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations.Invest Ophthalmol Vis Sci. 1991 Oct;32(11):2948-57. Invest Ophthalmol Vis Sci. 1991. PMID: 1917398
-
Light-dark variations in ocular timolol concentrations following topical solution instillation in the pigmented rabbit.Life Sci. 1992;51(26):2025-31. doi: 10.1016/0024-3205(92)90152-f. Life Sci. 1992. PMID: 1474859
-
Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol.J Ocul Pharmacol Ther. 1996 Summer;12(2):103-13. doi: 10.1089/jop.1996.12.103. J Ocul Pharmacol Ther. 1996. PMID: 8773926
-
Delivery of antiglaucoma drugs: ocular vs systemic absorption.J Ocul Pharmacol. 1994 Spring;10(1):349-57. doi: 10.1089/jop.1994.10.349. J Ocul Pharmacol. 1994. PMID: 8207339 Review.
-
Review: systemic absorption of topically applied ocular drugs in humans.J Ocul Pharmacol. 1990 Fall;6(3):243-9. doi: 10.1089/jop.1990.6.243. J Ocul Pharmacol. 1990. PMID: 2290070 Review.
Cited by
-
How can the bioavailability of timolol be enhanced? A pharmacokinetic pilot study of novel hydrogels.Graefes Arch Clin Exp Ophthalmol. 1996 Jul;234(7):452-6. doi: 10.1007/BF02539412. Graefes Arch Clin Exp Ophthalmol. 1996. PMID: 8817289
-
Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics.Br J Pharmacol. 2020 May;177(10):2215-2239. doi: 10.1111/bph.15017. Epub 2020 Mar 20. Br J Pharmacol. 2020. PMID: 32056195 Free PMC article. Review.
-
Effect of dosing schedule on pharmacokinetics of alpha interferon and anti-alpha interferon neutralizing antibody in mice.Antimicrob Agents Chemother. 2001 Jan;45(1):176-80. doi: 10.1128/AAC.45.1.176-180.2001. Antimicrob Agents Chemother. 2001. PMID: 11120962 Free PMC article.
-
Chronopharmacokinetics. Current status.Clin Pharmacokinet. 1998 Aug;35(2):83-94. doi: 10.2165/00003088-199835020-00001. Clin Pharmacokinet. 1998. PMID: 9739478 Review.
-
Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.Pharm Res. 1994 Sep;11(9):1278-82. doi: 10.1023/a:1018938310628. Pharm Res. 1994. PMID: 7816756
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources